Gustavo A. Barisone

861 total citations
27 papers, 692 citations indexed

About

Gustavo A. Barisone is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Gustavo A. Barisone has authored 27 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Oncology. Recurrent topics in Gustavo A. Barisone's work include Epigenetics and DNA Methylation (3 papers), Neuroblastoma Research and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). Gustavo A. Barisone is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Neuroblastoma Research and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). Gustavo A. Barisone collaborates with scholars based in United States, Argentina and China. Gustavo A. Barisone's co-authors include Elva Dı́az, Florin Despa, Charles DeCarli, Lee‐Way Jin, Marcelo O. Cabada, Ramón A. Lorca, James S. Trimmer, Durga P. Mohapatra, Angel A. Alvarez and Joseph M. Tuscano and has published in prestigious journals such as Neuron, The Journal of Immunology and PLoS ONE.

In The Last Decade

Gustavo A. Barisone

27 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo A. Barisone United States 13 355 246 129 69 59 27 692
Lavoisier Ramos‐Espiritu United States 10 334 0.9× 138 0.6× 105 0.8× 36 0.5× 40 0.7× 12 597
Refugio García‐Villegas Mexico 16 478 1.3× 117 0.5× 174 1.3× 114 1.7× 39 0.7× 33 822
M. Caleb Marlin United States 8 285 0.8× 113 0.5× 95 0.7× 60 0.9× 129 2.2× 13 586
Robert Dedecker Belgium 12 210 0.6× 287 1.2× 111 0.9× 64 0.9× 102 1.7× 14 696
Juliana Heidler Germany 22 706 2.0× 191 0.8× 76 0.6× 33 0.5× 94 1.6× 41 1.1k
Peter H. Frederikse United States 16 469 1.3× 238 1.0× 106 0.8× 67 1.0× 53 0.9× 27 716
Bernd Püschel Germany 14 488 1.4× 115 0.5× 299 2.3× 64 0.9× 75 1.3× 26 1.1k
Alicia Mansilla Spain 12 583 1.6× 175 0.7× 137 1.1× 84 1.2× 244 4.1× 20 1.0k
Michael Hamm United States 7 447 1.3× 113 0.5× 114 0.9× 39 0.6× 61 1.0× 14 701
Denise B. Flaherty United States 10 477 1.3× 263 1.1× 102 0.8× 84 1.2× 178 3.0× 15 907

Countries citing papers authored by Gustavo A. Barisone

Since Specialization
Citations

This map shows the geographic impact of Gustavo A. Barisone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo A. Barisone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo A. Barisone more than expected).

Fields of papers citing papers by Gustavo A. Barisone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo A. Barisone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo A. Barisone. The network helps show where Gustavo A. Barisone may publish in the future.

Co-authorship network of co-authors of Gustavo A. Barisone

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo A. Barisone. A scholar is included among the top collaborators of Gustavo A. Barisone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo A. Barisone. Gustavo A. Barisone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimoda, Michiko, Yuanzhi Lyu, Ashish Kumar, et al.. (2021). KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth. Communications Biology. 4(1). 1330–1330. 7 indexed citations
2.
Tuscano, Joseph M., Christina Poh, Aaron S. Rosenberg, et al.. (2020). Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia. Journal of Hematology. 9(3). 79–83. 2 indexed citations
3.
Barisone, Gustavo A., et al.. (2020). Bispecific anti-CD22 T-cell engager efficiently promotes cell-mediated cytotoxicity of lymphoma, leukemia and sarcoma targets. The Journal of Immunology. 204(1_Supplement). 239.27–239.27. 2 indexed citations
4.
Barisone, Gustavo A., et al.. (2018). A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation. PLoS ONE. 13(1). e0190860–e0190860. 12 indexed citations
5.
Kato, Jason, et al.. (2016). The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity. Cancer Immunology Immunotherapy. 65(10). 1169–1175. 6 indexed citations
6.
Kong, Yanguo, et al.. (2015). Efficacy of Combined Histone Deacetylase and Checkpoint Kinase Inhibition in a Preclinical Model of Human Burkitt Lymphoma. Molecular Medicine. 21(1). 824–832. 3 indexed citations
7.
Barisone, Gustavo A., Noriko Satake, Connie P.M. Duong, et al.. (2014). Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells. Blood Cells Molecules and Diseases. 54(4). 329–335. 14 indexed citations
8.
Alvarez, Angel A., Gustavo A. Barisone, & Elva Dı́az. (2014). Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene. Journal of Visualized Experiments. 16 indexed citations
9.
Kong, Yanguo, et al.. (2014). Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7. Leukemia Research. 38(11). 1320–1326. 3 indexed citations
10.
Barisone, Gustavo A., et al.. (2014). MXD3 regulation of DAOY cell proliferation dictated by time course of activation. BMC Cell Biology. 15(1). 30–30. 7 indexed citations
11.
Duong, Connie P.M., Cathy Chen, Gustavo A. Barisone, et al.. (2014). Abstract 5423: Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA. Cancer Research. 74(19_Supplement). 5423–5423. 1 indexed citations
12.
Barisone, Gustavo A., et al.. (2013). Amylin deposition in the brain: A second amyloid in Alzheimer disease?. Annals of Neurology. 74(4). 517–526. 285 indexed citations
13.
Barisone, Gustavo A., et al.. (2012). Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells. PLoS ONE. 7(7). e38508–e38508. 20 indexed citations
14.
Carneiro, K., Claudia Donnet, Tomáš Rejtar, et al.. (2011). Histone deacetylase activity is necessary for left-right patterning during vertebrate development. BMC Developmental Biology. 11(1). 29–29. 60 indexed citations
15.
16.
Barisone, Gustavo A., et al.. (2008). From cerebellar proliferation to tumorigenesis: New insights into the role of Mad3. Cell Cycle. 7(4). 423–427. 26 indexed citations
17.
Barisone, Gustavo A., Darío Krapf, Florencia Correa‐Fiz, Silvia E. Arranz, & Marcelo O. Cabada. (2006). Glycoproteins of the vitelline envelope of Amphibian oocyte: Biological and molecular characterization of ZPC component (gp41) in Bufo arenarum. Molecular Reproduction and Development. 74(5). 629–640. 12 indexed citations
18.
Barisone, Gustavo A., et al.. (2003). The envelopes of amphibian oocytes: physiological modifications in Bufo arenarum. Reproductive Biology and Endocrinology. 1(1). 18–18. 15 indexed citations
19.
Barisone, Gustavo A., Jerry L. Hedrick, & Marcelo O. Cabada. (2002). Vitelline Envelope of Bufo arenarum: Biochemical and Biological Characterization1. Biology of Reproduction. 66(4). 1203–1209. 20 indexed citations
20.
Barisone, Gustavo A., Félix V. Vega, Fernando Domı́nguez, & Marcelo O. Cabada. (1998). Detection of prothymosin alpha in oocytes and embryos of Bufo arenarum. Zygote. 6(4). 347–350. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026